Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.45K Buy
12
+8
+200% +$874 ﹤0.01% 1450
2026
Q1
$333 Sell
4
-63
-94% -$5.4K ﹤0.01% 1524
2025
Q4
$5.73K Sell
67
-7
-9% -$585 ﹤0.01% 1199
2025
Q3
$6.18K Sell
74
-44
-37% -$4.02K ﹤0.01% 1169
2025
Q2
$12K Sell
118
-98
-45% -$9.99K ﹤0.01% 1084
2025
Q1
$22.9K Sell
216
-201
-48% -$20.8K ﹤0.01% 948
2024
Q4
$45.7K Sell
417
-236
-36% -$27.5K ﹤0.01% 825
2024
Q3
$94.6K Sell
653
-9
-1% -$1.23K ﹤0.01% 664
2024
Q2
$96.6K Sell
662
-45
-6% -$6.31K ﹤0.01% 665
2024
Q1
$102K Sell
707
-481
-40% -$54.8K ﹤0.01% 676
2023
Q4
$111K Sell
1,188
-923
-44% -$85.2K ﹤0.01% 646
2023
Q3
$186K Sell
2,111
-1,454
-41% -$149K 0.01% 555
2023
Q2
$401K Buy
+3,565
New +$425K 0.01% 451

Other funds holding CROX

Central Trust Company's CROX Position: Q2 2026 in Review

Central Trust Company increased its Crocs (CROX) stake by 200% in Q2 2026, buying an estimated $874 and bringing the position to 12 shares worth $1.45K. The position accounts for ﹤0.01% of the portfolio, ranked #1450.

Central Trust Company first reported a position in CROX in Q2 2023 and has held it in 13 quarters since. The position peaked at $401K in Q2 2023. 140 funds tracked by Wall St. Rank hold CROX as of Q2 2026.

  • Central Trust Company held 12 shares of Crocs worth $1.45K as of Q2 2026.
  • Central Trust Company bought 8 Crocs shares in Q2 2026, an estimated $874.
  • Crocs made up ﹤0.01% of Central Trust Company's portfolio in Q2 2026, its #1450 holding.
  • Central Trust Company first reported a position in Crocs in Q2 2023 and has held it in 13 quarters since.
  • Central Trust Company's Crocs position peaked at $401K in Q2 2023.
  • 140 funds tracked by Wall St. Rank held Crocs as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.